Category: CovidienSyndicate content

Medtronic, Covidien set timetable for shareholders meetings

November 17, 2014 by Brad Perriello

Medtronic and Covidien set the timetable for shareholder meetings to vote on their pending, $43 billion merger.

Medtronic, Covidien set timetable for shareholders meetings

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

DeviceTalks closes 2014 season in Orange County this week

November 17, 2014 by Brian Johnson

Pioneering live interview series from MassDevice.com will close its 2014 season this week in Irvine, Calif. with Masimo CEO Joe Kiani and Caroll Neubauer, CEO, B. Braun Medical.

MassDevice.com On Call

DeviceTalks, the live interview series featuring thought leaders from the $126B medical technology industry, closes out its 2014 season on November 19, 2014 in Irvine, Calif. with a conversation focused on whether the medical device industry is doing enough to protect patients.

Covidien study: VenaSeal effective in treating leg veins

November 17, 2014 by Val Kennedy

A Covidien study has shown that its new VenaSeal system is just as effective in treating chronic leg vein disorders as its ClosureFast ablation catheter.

Covidien study: VenaSeal effective in treating leg veins

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Report: Medtronic readies $10B bond flotation for Covidien deal

November 17, 2014 by Brad Perriello

Medtronic is reportedly preparing to float $10 billion worth of bonds to help fund its $43 billion acquisition of Covidien.

Report: Medtronic readies $10B bond flotation for Covidien deal

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

MDT inks package of loans worth more than $16B to back its $43B acquisition of COV | Medtech Wall Street news for the week of November 10, 2014

November 13, 2014 by MassDevice

Here's a look at some of the top Wall Street stories for medical device companies this week: Medtronic inks $16B loan package for Covidien buyout; Second Sight eyes $32m IPO; The silver lining for healthcare in U.S. inversion rules; Survey: Hospitals clamp down on medical device expenses; Nevro boosts IPO to $126m

Medtronic inks $16B loan package for Covidien buyout

November 10, 2014 by Brad Perriello

Medtronic inks package of loans worth more than $16 billion to back its $43 billion acquisition of Covidien | The week in medtech M&A

November 12, 2014 by MassDevice

Here's a look at some of the top mergers & acquisitions stories for medical device companies this week: Medtronic inks $16B loan package for Covidien buyout; The silver lining for healthcare in U.S. inversion rules; SV Life Sciences buys majority stake in Ximedica; Wright Medical slashes losses, Q3 sales surge; Salix inventory snafu sinks deal with Allergan

Medtronic inks $16B loan package for Covidien buyout

November 10, 2014 by Brad Perriello

Medtronic offers EU concessions in $43 billion Covidien deal

November 11, 2014 by MassDevice

Medtronic agrees to concessions to mollify European anti-trust regulators over its $43 billion buyout of Covidien.

Medtronic offers EU concessions in $43 billion Covidien deal

Get the complete picture with a MassDevice Plus membership. Registered users can login here.